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Rapid detection of Clostvidium dificile toxin A in stool 
specimens 
Fre'de'ric Barbut *, Muriel Mace'*, Valkrie Lalande ', Patrick Tilled' 
andlean-Claude Petit' 
Service de Bactkriologie-Virologie et  'Pharmacie, HBpital Saint-Antoine, Paris, France 
Objective: To evaluate a rapid (15-min) enzyme immunoassay in the format of an individual cassette (ImmunoCard 
toxin A, Meridian, BMD, Marne-la-Vallee, France) for the detection of Clostridium difficile toxin A in stool specimens. 
Methods: We compared this new test with the cytotoxicity assay using MRC-5 cells, the ToxA test (TechLab, 
BioWhittaker, Fontenay-sous-bois, France) and toxigenic culture for the diagnosis of C. difficile-associated diseases 
(CDAD). A total of 236 stool specimens collected from 220 patients was simultaneously tested with the four methods. 
Discordant results were resolved by reviewing patients' clinical records. 
Results: The prevalence of CDAD was 13.9%. Test sensitivities and specificities were 100% and 99% respectively for 
the cytotoxicity assay, 87.5% and 100% for ImmunoCard toxin A, 77.4% and 100% for the ToxA test and 100% and 98% 
for toxigenic culture. 
Conclusions: The ImmunoCard Toxin A is a very rapid, individual and easy-to-perform test for the diagnosis of CDAD. 
It provides same-day results and may be useful for both guiding appropriate treatment and controlling nosocomial 
spread of C. difficile. 
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Clortridium dficile-associated diseases (CDAD) include 
a spectrum of syndromes ranging from antibiotic- 
associated diarrhea to pseudomembranous colitis [ 1-41, 
Recent multicenter study showed that 11.5% of 
hospitalized patients with diarrheal stools harbor C. 
d f i c i l e  [5]. This anaerobic bacterium has become the 
commonest agent of nosocomial diarrhea in adults in 
industrialized countries [6,7]. Toxigenic strains of C. 
dificile produce two toxins (toxins A and B) which 
are implicated in the pathogenicity of CDAD [4]. 
Laboratory diagnosis relies on culture of the micro- 
organism and/or detection of the toxins in stool 
specimens IS]. Many inimunoenzymatic assays that 
detect either toxin A or toxins A+B have become 
commercially available in the 5 last years [9-181. They 
represent good alternatives to cytotoxicity assays for 
laboratories without cell-culture facilities. Neverthe- 
less, most of these tests require at  least 2 h to be 
performed and their use is limited by their expense. 
There is a need for a very rapid, accurate and easy- 
to-perform screening test. We therefore evaluated the 
effectiveness of IinmunoCard toxin A (Meridian, 
BMD, Marne-la-Vallie, France) for the diagnosis 
of CDAD. This test is a rapid (less than 15 min) and 
individual enzyme immunoassay that detects toxin A 
in human stools. 
MATERIALS AND METHODS 
Stool collection 
We undertook a prospective study of 236 stool 
specimens collected from 220 patients suspected of 
having CDAD. Stool specimens were submitted to the 
laboratory of Saint-Antoine hospital over a 2-month 
period in 1996. Each fresh stool was siniultaneously 
tested with four different methods: ImmunoCard toxin 
A, cytotoxicity assay, toxigenic culture and the ToxA 
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test. The results of each method were recorded without 
knowledge of the results of other methods. 
In cases of discordant or equivocal results, stool 
specimens were tested again with the four methods. 
Whenever the results of these methods were not 
concordant, the patients’ charts were reviewed. Patients 
were considered to have CDAD if they niet the follow- 
ing criteria: (1) a positive result by at least one of the 
above methods; (2) the presence of diarrhea for at  least 
2 days; (3) antibiotic usage in the previous 3 weeks; and 
(4) no other documented gastrointestinal pathogens. 
Culture 
Fresh stool specimens were inoculated on a medium 
selective for C. d f i c i l e  (brain-heart agar supplemented 
with 5% defibrinated horse blood, 0.1% sodium tauro- 
cholate, 250 nig/L cycloserine and 10 mg/L cefoxitin) 
and plates were incubated anaerobically for 48 h. The 
identification of suspect colonies (based on characteristic 
morphology, odor and Gram staining) was confirmed 
by biochemical testing (Rapid ID32A, bioMkrieux, La 
Balme-les-Grottes, France). 
Stool cytotoxicity assay 
The stool cytotoxicity assay was performed as described 
previously [lo]. Briefly, fresh stool specimens were 
diluted 1 : 10 in phosphate-buffered saline and centri- 
fuged at 2500g for 30 min. The supernatant was filtered 
through a 0.45-pm-pore filter and inoculated onto a 
confluent monolayer of human embryonic lung fibro- 
blast cells (MRC-5) in 96-well microtiter plates that 
were incubated at 37OC in an atmosphere containing 
6.5% COL for 24h .  A neutralization assay using C. 
sordellii antitoxin was performed on samples which 
demonstrated cytopathic effect. 
Following isolation of C. d&cile, cultures were 
assessed for the production of toxin B. Three to four 
colonies were inoculated into TYG broth culture 
(Trypticase Yeast Glucose, Diagnostics Pasteur, Marne- 
la-Coquette, France) and incubated for 5 days under 
anaerobic conditions. The supernatant from this culture 
was inoculated onto MRC-5 cells as above. 
ImmunoCard toxin A (Meridian, BMD, Marne-la-Vallee, 
France) 
Fresh stools were diluted 1 :5 in diluent plus enzyme 
conjugate (C. d@de  toxin A specific monoclonal anti- 
body conjugated to horse radish peroxidase), vortexed 
and added to each of the two sample ports of an 
individual membrane cassette which contained either 
immobilized antitoxin A (test reaction port) or toxin A 
(control reaction port). After 5 min, the reaction ports 
were washed and the substrate was added for a further 
5 min. The appearance of a blue color in both the 
reaction test and the positive control ports was con- 
sidered a positive test for toxin A. If the expected blue 
color of the control port was not observed, the result 
was considered invalid. 
Tox-A test (Techlab, biowhittaker, Fontenay-sous-Bois, 
France) 
This test was performed according to the manu- 
facturer’s instructions. Positive and negative controls 
were included in each run. Stool samples were diluted 
I : 2 in diluent and 100 pl was added to 96-weU micro- 
titration plates coated with toxin A polyclonal antibody. 
One drop of toxin A monoclonal antibody linked to 
horse-radish peroxidase was added. Plates were incu- 
bated for 2 h at  37°C. After five washes, one drop of 
substrate solution was added and plates were incubated 
for 15 min. Results were read spectrophotonietrically 
and the optical densities (ODs) interpreted according 
to the manufacturer’s guidelines: ODs < 0.1 were con- 
sidered negative, ODs >0.2 were considered positive 
and ODs between 0.1 and 0.2 were considered 
equivocal. 
Table 1 Analysis of the 17 samples yielding; indeterminate, invalid or discrepant results after repeat testing 
No. of Cytotoxin ImmunoCard Toxigenic CDAD 
cases assay T(m4 test toxin A culture cases 
2 
2 
1 
1 
3 
1 
1 
1 
2 
3 
+ 
+ 
- 
- 
Ind 
+ 
+ 
+ 
- 
- 
+ 
+ 
- 
+ 
+ 
+ 
Ind=Indeterminate results: Inv=Invalid results 
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RESULTS 
Of the 236 stool specimens, 219 gave the same results 
with all four methods (23 were positive and 196 were 
negative). Seventeen stool samples gave discordant, 
equivocal or invalid results. Those discordant results 
are summarized in Table I .  Diagnosis of CDAD was 
resolved after review of patients’ charts: 3 0 were con- 
sidered positive and seven were considered negative 
for the diagnosis of CDAD. The overall prevalence of 
CDAD was 13.9%. Performances of the four methods 
are summarized in Table 2. ImniunoCard toxin A and 
the ToxA test gave 1.3% and 1.7% invalid or equivocal 
results respectively, even after repeated testing. No 
false positives were noted with these two methods. 
ImmunoCard and ToxA test yielded six and nine false- 
negative results respectively. Cytotoxicity assay and 
toxigenic culture gave two and four false-positive results 
respectively and no false-negative results. Eleven stools 
(4.7%)) harbored non-toxigenic C. df ic i le  strains. 
DISCUSSION 
The laboratory diagnosis of CDAD is based on detection 
of the organism and/or its toxins in stool specimens [8]. 
Culture is usually performed on selective medium and 
the isolation rate depends on the concentration of 
cycloserine and cefoxitin and on the use of taurocholate 
and lysozyme [19]. This method needs at least 48 h of 
incubation and does not indicate whether or not the 
strain is toxigenic; toxin assays must subsequently be 
performed on isolated strains. Although this strategy of 
diagnosis is considered to be the most sensitive, it is also 
time-consuming and labor-intensive [10,17]. Because 
stool samples can harbor both toxigenic and non- 
toxigenic strains of C. d f i c i t e ,  it is also necessary to test 
several colonies to avoid false-negative results 1201. 
Tissue-culture cytotoxicity assay is still considered the 
‘gold standard’ method for identifjring CDAD, but this 
method is labor-intensive, poorly standardized, and 
unavailable in many laboratories. 
Several immunoenzymatic methods detecting toxin 
A alone or toxins A+B simultaneously have become 
commercially available in the last 5 years and have 
significantly simplified the laboratory diagnosis of 
CDAD. They can be performed in approximately 2 h 
and have generally shown good specificity. Never- 
theless, their sensitivity varies from 53% to 100% 
according to different studies [9-11,13-181, with 
discrepancies explained by the criteria used for the 
diagnosis of CDAD. In the present study, the sensitivity 
of the ToxA test was estimated to be 77.4%, which is 
lower than the 84.6% reported by SchuC et al. [16] 
using the the same clinical criteria for diagnosis of 
CDAD. Such ininiunoenzymatic methods provide a 
good alternative for laboratories without tissue-culture 
facilities but their use is often limited by their expense, 
particularly when specimen numbers are low. For this 
reason and because negative and positive controls must 
be included in each run, microbiologists often delay 
runs until they have several stool specimens to be tested. 
Rapid diagnosis of C. dgficile in patients with 
antibiotic-associated diarrhea or pseudomembranous 
colitis is of primary importance as it guides both 
the treatment and control of nosocomial spread of 
infection. Woods and Iwen [21] evaluated a dot im- 
munoassay which detected toxin A in 20 min and 
showed a correlation of 92% with the cytotoxicity assay. 
However, this test has never become commercially 
available. More recently, we evaluated a very rapid 
enzyme immunoassay for the detection of C. d f i c i l e -  
specific antigen and we concluded that the good 
negative predictive value of this test made it particularly 
suitable for the rapid screening of specimens [22]. 
However, all positive results had to be confirmed by 
toxin detection before a definitive diagnosis of CDAD 
could be established. 
The need for a very rapid, accurate and easy-to- 
perform method led us to evaluate ImmunoCard toxin 
A. This test is different from the other immuno- 
enzymatic assays because it can be performed in less 
than 15 niin and each ImmunoCard toxin A cassette 
contains an integrated positive control. The results of 
this study suggest that the performance of Immuno- 
Card toxin A is equivalent to that obtained with other 
immunoenzymatic methods. ImmunoCard toxin A gave 
Table 2 Characteristics o f  the tests for the diagnosis of Clostvidiurn dijficilicile-associated diseases 
Predictive value (96) 
Sendtivity Specificity Correlation 
Test (%) (%I) Positive Negative (“w 
Cytotoxicity assay 100 99 94.4 100 99.2 
Toxigenic culture 100 98 89.2 100 98.3 
ToxA Test 77.4 100 100 96.6 95.3 
ItniiiuiioCalrd toxin A 87.5 100 100 98.5 97 
Correlation is defined by the overall agreement of each method with the diagnosis of C. dfjcile-associated diarrhea 
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three invalid results: two were subsequently considered 
positive for the diagnosis of CDAD and one negative. 
An invalid result (no detectable color in the control 
reaction port) may be due to the overinoculation 
of stool (especially formed stools) during specimen 
dilution, which prevents the sample fiom migrating 
along the membrane and through the reaction port. 
For this reason, and also because the sensitivity of 
InimunoCard toxin A is only 87.5%, we would recom- 
mend further complementary tests if the diagnosis of 
CDAD is still suspected in the light of a negative/ 
invalid result. Nevertheless, we consider that the 
InimunoCard toxin A test is a valuable option for 
laboratories without facilities for cytotoxicity assays. It 
could be particularly useful whenever same-day results 
are deemed essential. Because it combines speed and 
good performance, its place among other methods used 
for the diagnosis of CDAD requires further evaluation, 
particularly in outbreak situations. 
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